Table 1.
T0 baseline | T0 after tDCS | T1 day 12 | T2 3 months | T3 6 months | T4 12 months | |
---|---|---|---|---|---|---|
Questionnaires | ||||||
EQ-5D-5L | X | X | X | X | X | |
PHQ-9 | X | X | X | X | X | |
POMS 32-item | X | X | X | X | X | |
iMCQ | X | X | ||||
IPAQ parts 1 and 4 | X | X | X | |||
FARS part II (ADL) | X | X | X | X | X | |
Neurological examination | ||||||
CCAS scale | X | X | X | X | X | |
SARA | X | X | X | X | X | X |
8MWT | X | X | X | X | X | X |
9HPT | X | X | X | X | X | X |
PATA repetition | X | X | X | X | X | X |
INAS | X | X | X | X | X | |
Measurements | ||||||
TMS | X | X | ||||
Delay EBC | X | X | ||||
Static posturography | X | X | X |
EQ-5D-5L EuroQol 5-Dimension 5-Level, PHQ-9 Patient Health Questionnaire-9, POMS Profile of Mood States, iMCQ Institute for Medical Technology Assessment (iMTA) Medical Consumption Questionnaire, IPAQ International Physical Activity Questionnaire; FARS Friedreich Ataxia Rating Scale, ADL Activities of Daily Living, CCAS Cerebellar Cognitive Affective Syndrome, SARA Scale for the Assessment and Rating of Ataxia, 8MWT 8 m walk test, 9HPT 9-hole peg test, INAS Inventory of Non-Ataxia Signs, TMS Transcranial magnetic stimulation, EBC Eyeblink conditioning